These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9845116)

  • 21. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Zhong L; Chen JJ; Chen J; Li L; Lin ZQ; Wang WJ; Xu JR
    J Dig Dis; 2009 Nov; 10(4):315-20. PubMed ID: 19906112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
    Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of metabolic abnormality in asynergic regions of ischemic human myocardium using 31P and 1H magnetic resonance spectroscopy.
    Nakae I; Mitsunami K; Yabe T; Inubushi T; Morikawa S; Matsuo S; Koh T; Horie M
    J Cardiovasc Magn Reson; 2004; 6(3):685-96. PubMed ID: 15347133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers.
    Wang H; Cona MM; Chen F; Yu J; Feng Y; Li J; Keyzer FD; Marchal G; Ni Y
    Anticancer Drugs; 2012 Jan; 23(1):12-21. PubMed ID: 21857503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of liquid phase cholesteryl ester in carotid atherosclerosis by 1H-MR spectroscopy in humans.
    Duivenvoorden R; van Wijk D; Klimas M; Kastelein JJ; Stroes ES; Nederveen AJ
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1277-84. PubMed ID: 24269263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods.
    Rodrigues LM; Stubbs M; Robinson SP; Newell B; Mansi J; Griffiths JR
    MAGMA; 2004 Dec; 17(3-6):260-70. PubMed ID: 15703983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.
    Grosios K; Holwell SE; McGown AT; Pettit GR; Bibby MC
    Br J Cancer; 1999 Dec; 81(8):1318-27. PubMed ID: 10604728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI and MRS studies on acute effects of ethanol in the rat brain.
    Hirakawa K; Uekusa K; Sato S; Nihira M
    Nihon Hoigaku Zasshi; 1994 Apr; 48(2):63-74. PubMed ID: 8196210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivity.
    Saitoh J; Sakurai H; Suzuki Y; Muramatsu H; Ishikawa H; Kitamoto Y; Akimoto T; Hasegawa M; Mitsuhashi N; Nakano T
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):903-9. PubMed ID: 12377344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
    Lemaire LP; McSheehy PM; Griffiths JR
    Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS.
    Beauregard DA; Pedley RB; Hill SA; Brindle KM
    NMR Biomed; 2002 Apr; 15(2):99-105. PubMed ID: 11870905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours.
    Bhujwalla ZM; McCoy CL; Glickson JD; Gillies RJ; Stubbs M
    Br J Cancer; 1998 Sep; 78(5):606-11. PubMed ID: 9744499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum.
    Pettit GR; Singh SB; Schmidt JM; Niven ML; Hamel E; Lin CM
    J Nat Prod; 1988; 51(3):517-27. PubMed ID: 3404149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.
    Liu YW; De Keyzer F; Feng YB; Chen F; Song SL; Swinnen J; Bormans G; Oyen R; Huang G; Ni YC
    World J Gastroenterol; 2018 Jul; 24(25):2710-2721. PubMed ID: 29991876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.
    Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC
    Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of tumour perfusion and oxygenation monitored by gradient recalled echo MRI and 31P MRS.
    Howe FA; Robinson SP; Griffiths JR
    NMR Biomed; 1996 Aug; 9(5):208-16. PubMed ID: 9068002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
    Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
    Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combretastatin A4 phosphate].
    Verdier-Pinard P; Lansiaux A; Bailly C
    Bull Cancer; 2001 Mar; 88(3):235-9. PubMed ID: 11313199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.